Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern



Status:Completed
Conditions:Angina, Peripheral Vascular Disease, Peripheral Vascular Disease, Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:21 - 99
Updated:2/2/2019
Start Date:November 2010
End Date:June 2012

Use our guide to learn which trials are right for you!

Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern

To investigate whether the use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood
assay changes the diagnostic testing pattern in patients referred to a cardiologist for the
evaluation of chest pain or anginal equivalent symptoms.

A prospective cohort of 88 subjects receiving the Corus CAD (Age/Sex/Gene Expression score -
ASGES) assay were compared to a retrospective cohort of 83 subjects that did not receive the
assay.

Inclusion Criteria:

1. Stable chest pain, typical or atypical angina or anginal equivalent

2. The patient has signed the appropriate Institutional Review Board approved Informed
Consent Form.

Exclusion Criteria:

1. History of myocardial infarction

2. Current myocardial infarct (MI) or acute coronary syndrome

3. Current New York Heart Association (NYHA) class III or IV congestive heart failure
symptoms

4. Any previous coronary revascularization

5. Any individuals with:

1. Diabetes

2. Suspected unstable angina

3. Systemic infections

4. Systemic inflammatory conditions

6. Any individuals currently taking:

1. Steroids

2. Immunosuppressive agents

3. Chemotherapeutic agents

7. Recipient of any organ transplant
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials